We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$495M
AUM Growth
+$20.4M
Cap. Flow
+$3.66M
Cap. Flow %
0.74%
Top 10 Hldgs %
35.14%
Holding
75
New
3
Increased
44
Reduced
22
Closed
3

Sector Composition

1 Industrials 19.69%
2 Consumer Discretionary 18.3%
3 Technology 18.17%
4 Financials 14.92%
5 Consumer Staples 11.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRL icon
26
Cracker Barrel
CBRL
$1.2B
$9.07M 1.83%
53,149
+1,529
+3% +$250K
EV
27
DELISTED
Eaton Vance Corp.
EV
$8.99M 1.82%
208,506
+9,511
+5% +$388K
DEO icon
28
Diageo
DEO
$46.7B
$8.96M 1.81%
51,988
+1,755
+3% +$295K
ORLY icon
29
O'Reilly Automotive
ORLY
$71.3B
$8.51M 1.72%
345,525
+1,380
+0.4% +$35K
NVO
30
Novo Nordisk
NVO
$223B
$8.1M 1.64%
317,340
+2,720
+0.9% +$67.2K
CNI icon
31
Canadian National Railway
CNI
$78.3B
$7.86M 1.59%
84,959
+1,811
+2% +$166K
SYK icon
32
Stryker
SYK
$123B
$7.57M 1.53%
36,816
+1,011
+3% +$193K
EXPD icon
33
Expeditors International
EXPD
$23.9B
$7.43M 1.5%
97,969
+8,489
+9% +$641K
DLTR icon
34
Dollar Tree
DLTR
$24.2B
$7.11M 1.44%
66,252
-3,886
-6% -$409K
PII icon
35
Polaris
PII
$4.16B
$6.15M 1.24%
67,389
+1,016
+2% +$92.5K
HSIC icon
36
Henry Schein
HSIC
$10B
$5.3M 1.07%
75,868
+3,249
+4% +$215K
UNH icon
37
UnitedHealth
UNH
$387B
$4.65M 0.94%
19,061
+3,182
+20% +$765K
ABBV icon
38
AbbVie
ABBV
$450B
$4.57M 0.92%
62,815
+22
+0% +$1.73K
LEA icon
39
Lear
LEA
$7.1B
$3.8M 0.77%
27,283
+1,413
+5% +$198K
RTN
40
DELISTED
Raytheon Company
RTN
$3.75M 0.76%
21,593
+476
+2% +$85.6K
LLY icon
41
Eli Lilly
LLY
$1.05T
$3.45M 0.7%
31,114
+2,840
+10% +$334K
FDS icon
42
Factset
FDS
$9.18B
$3.43M 0.69%
11,980
-75
-0.6% -$20.8K
CACC icon
43
Credit Acceptance
CACC
$6.69B
$3.38M 0.68%
6,987
+2,196
+46% +$1.04M
SLGN icon
44
Silgan Holdings
SLGN
$4.99B
$3.14M 0.63%
102,611
-81,382
-44% -$2.43M
SHW icon
45
Sherwin-Williams
SHW
$81.7B
$2.99M 0.6%
19,578
+57
+0.3% +$8.52K
KMB icon
46
Kimberly-Clark
KMB
$36B
$2.83M 0.57%
21,240
-180
-0.8% -$23.2K
ICLR icon
47
Icon
ICLR
$13.1B
$2.79M 0.56%
18,137
+13,622
+302% +$1.91M
RHI icon
48
Robert Half
RHI
$4.28B
$2.68M 0.54%
47,037
+3,144
+7% +$188K
INTC icon
49
Intel
INTC
$478B
$1.95M 0.39%
40,744
+2,857
+8% +$142K
MTD icon
50
Mettler-Toledo International
MTD
$26.5B
$1.9M 0.38%
2,263

Similar funds

JLB & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, JLB & Associates held 75 positions worth $495M, up 4.3% from $474M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

JLB & Associates's Q2 2019 filing shows 3 new, 44 increased, 22 reduced and 3 closed positions. Its largest new stake was CBRE Group: 25,244 shares worth $1.29M. The largest sale was Silgan Holdings, an estimated $2.43M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JLB & Associates's largest Q2 2019 buy was CBRE Group: 25,244 shares worth $1.29M.
  • JLB & Associates added most to Icon in Q2 2019, an estimated $1.91M increase.
  • JLB & Associates's biggest Q2 2019 reduction was Silgan Holdings, cutting an estimated $2.43M.
  • JLB & Associates fully exited Labcorp in Q2 2019, selling an estimated $622K.
  • JLB & Associates's ten largest holdings make up 35% of its $495M portfolio in Q2 2019.
  • JLB & Associates opened 3 new positions and closed 3 in Q2 2019.
  • JLB & Associates's portfolio value rose 4.3% quarter-over-quarter to $495M.

Based on JLB & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.